Treatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19)

2.50
Hdl Handle:
http://hdl.handle.net/10755/622478
Category:
Full-text
Format:
Text-based Document
Type:
Poster
Level of Evidence:
N/A
Research Approach:
N/A
Title:
Treatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19)
Author(s):
Morrison, Felicia M.
Lead Author STTI Affiliation:
Omicron
Author Details:
Felicia M. Morrison, MSN, MBA, Staffing for All Seasons, Hopsital of the University of Pennsylviania, Philadlephia, PA, USA
Abstract:

Treatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19Treatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19).

Keywords:
Chimeric Antigen Receptor T-cells therapy (CART-19); Chronic Lymphocytic Leukemia; Cytokine Release Syndrome
Repository Posting Date:
28-Jul-2017
Date of Publication:
28-Jul-2017
Other Identifiers:
INRC17PST645
Conference Date:
2017
Conference Name:
28th International Nursing Research Congress
Conference Host:
Sigma Theta Tau International
Conference Location:
Dublin, Ireland
Description:
Event Theme: Influencing Global Health Through the Advancement of Nursing Scholarship

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePosteren
dc.evidence.levelN/Aen
dc.research.approachN/Aen
dc.titleTreatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19)en_US
dc.contributor.authorMorrison, Felicia M.en
dc.contributor.departmentOmicronen
dc.author.detailsFelicia M. Morrison, MSN, MBA, Staffing for All Seasons, Hopsital of the University of Pennsylviania, Philadlephia, PA, USAen
dc.identifier.urihttp://hdl.handle.net/10755/622478-
dc.description.abstract<p><span>Treatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19Treatment Options for Chronic Lymphocytic Leukemia Tumors Chimeric Antigen Receptor Modified T Cells Therapy (CART-19).</span></p>en
dc.subjectChimeric Antigen Receptor T-cells therapy (CART-19)en
dc.subjectChronic Lymphocytic Leukemiaen
dc.subjectCytokine Release Syndromeen
dc.date.available2017-07-28T13:59:00Z-
dc.date.issued2017-07-28-
dc.date.accessioned2017-07-28T13:59:00Z-
dc.conference.date2017en
dc.conference.name28th International Nursing Research Congressen
dc.conference.hostSigma Theta Tau Internationalen
dc.conference.locationDublin, Irelanden
dc.descriptionEvent Theme: Influencing Global Health Through the Advancement of Nursing Scholarshipen
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.